GMP Oligos for Clinical Supply
Tailored manufacturing grades
Clinical GMP Quality for Oligonucleotides
Advanced Technologies for Clinical Readiness
BioSpring uses industry-leading oligonucleotide manufacturing technologies to deliver high-quality material for clinical development. Built on three decades of experience, our development capabilities support seamless transitions between clinical phases without compromising quality, compliance, or timelines. We offer established platform processes and methods for streamlined development and scale-up, alongside the flexibility to work with client-defined processes. We support ICH-compliant, stage-appropriate analytical method development and validation, from early-stage development through the clinical phases and beyond.
State-Of-The-Art Facilities for Flexible Scaling
Our GMP-certified, FDA- and ANVISA-inspected facilities support batch sizes from grams to tens of kilograms.
Decades of Clinical Expertise
BioSpring has manufactured APIs for hundreds of clinical trials worldwide, combining technical expertise with a proven track record of reliability and on-time delivery. Our regulatory support team supports your program with the preparation of scientific advice meetings, dossier sections, and review of global submissions including INDs, IMPDs, NDAs, MAAs, J-NDAs, and BLAs.
Accelerate your success with us:
Reduce CMC risk, keep timelines predictable, and progress confidently to submission and launch.
